"Emerging Infectious Diseases" -- a panel discussion, 27 July 2011 (Weds), 6-8 PM, San Diego, Calif.

---

"Emerging Infectious Diseases: R&D Strategies and Business Opportunities" -- a panel discussion, 27 July 2011 (Weds), 6-8 PM, San Diego, Calif.


If you have sincere interest, please join us for the first FREE, in situ plasmid-swapping meeting in San Diego of the new LinkedIn.com group:


-->>  Infectious Disease R&D and Business Network

-->>  http://www.linkedin.com/e/-ubgx8c-godydbie-43/vgh/3937807/


And we encourage group members not near San Diego to organize and hold their own similar quorum-sensing plenary all-hands meetings in other cities around the world.


ABSTRACT:

Few areas of drug & vaccine development offer such unlimited business opportunities as Infectious Diseases. 

In addition to vast unmet medical needs for well-recognized pathogens such as HCV, HBV, HIV, HPV, HSV, VZV, EBV, CMV and DPV -- and in addition to burgeoning drug resistance as evidenced by methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and the fatal endemic pathogenic E. coli strains now rampant in Germany -- new infectious agents now appear almost annually somewhere worldwide, such as novel influenza strains -- the bird flu, swine flu and Hong Kong flu -- as well as the Ebola & Marburg viruses in Africa.

This panel discussion will highlight new R&D and business opportunities arising from emergent pathogens and discuss possible strategies for their containment prior to the approval of countervailing therapeutic agents.

If you love the smell of infectious diseases in the morning, please join us for this **FREE** meeting kindly sponsored by the law firm of Sheppard Mullin.


WHEN:  27 July 2011 (Weds), 6-8 PM


Confirmed PANELIST:

Victor Nizet, Ph.D.
Division of Pediatric Pharmacology & Drug Discovery
UCSD School of Medicine
Cellular & Molecular Medicine
UCSD
La Jolla, CA
email:  vnizet@ucsd.edu
http://nizetlab.ucsd.edu


PLUS ! -- other PANELISTS INVITED FROM:

Trius Therapeutics
Optimer Pharmaceuticals
Scripps
Sofinnova Ventures
Synthetic Genomics Vaccines


MODERATOR:

David Palella
Founder
BIOSCIENCE VENTURES Inc.
San Diego, California
cell: 619-787-5767
email:  dpalella@gmail.com
http://www.linkedin.com/in/davidpalella
web site:  http://www.BSVpartners.com
blog:  http://biobizdev.blogspot.com


WHERE -- & Your host for the evening:

Ms. Amy ROMAKER
Client Service Team
SHEPPARD MULLIN
12275 El Camino Real
Suite 200
San Diego CA 92130-2006

direct tel: 858-720-7403
main tel: 858-720-8900
email:  aromaker@sheppardmullin.com
http://www.sheppardmullin.com


REMINDER:  This is a *FREE* meeting, courtesy of Sheppard Mullin.


NOTA BENE:  NO formal registration is needed; we don't complicate your lives!


For more info & to RSVP, contact:

David A. Palella
BIOSCIENCE VENTURES Inc.
“Global Corporate Development for Biopharmaceuticals since 1991”
San Diego, Calif.

cell: 619-787-5767
email:  dpalella@gmail.com
http://www.linkedin.com/in/davidpalella
web site:  http://www.BSVpartners.com
blog:  http://biobizdev.blogspot.com

---------


POSTED 02 July 2011 @ 3:30 AM by:

David A. Palella
Founder
BIOSCIENCE VENTURES Inc.
“Global Corporate Development for Biopharmaceuticals since 1991”

San Diego, California
cell: 619-787-5767
email:  dpalella@gmail.com
http://www.linkedin.com/in/davidpalella

web site:  http://www.BSVpartners.com

blog:  http://biobizdev.blogspot.com


& Group Founder:

Infectious Disease R&D and Business Network
http://www.linkedin.com/e/-ubgx8c-godydbie-43/vgh/3937807/

Japan Biotech/Biopharma Partnering Forum
http://www.linkedin.com/e/vgh/2857975/

Asia Business & Finance Roundup
http://www.linkedin.com/e/vgh/3132759/

San Diego Biofuels & Sustainable Chemicals Networking Group
http://www.linkedin.com/e/vgh/3891375/

X-tech Roundup(SM) - San Diego
http://www.linkedin.com/e/vgh/2836926


& Co-founder:

Stem Cells & Regenerative Medicine
http://www.linkedin.com/e/vgh/3921448


------